SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

SGX Healthcare Index Outperformed Asian Benchmark in YTD

Special Situations, Content Strategist, Smartkarma

Crispin Francis

Special Situations, Content Strategist

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Event-Driven

On 16 February 2017, <a href="https://www.smartkarma.com/entities/9984" target="_blank" data-smartkarma-citation="entities:9984:1">Oue Ltd (OUE SP)</a> made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in <a href="https://www.smartkarma.com/entities/562" target="_blank" data-smartkarma-citation="entities:562:1">International Healthway Corporation Ltd (IHC SP)</a>. The MGO was triggered after OUE entered into an S&amp;P agreement with Ching Chiat Kwong, Low See Ching, Low Bee Lan Audrey and Tee Wee Sien (collectively, the "Vendors") for the purchase of 593.5m shares at SGD 0.106 / share. This Acquisition will be completed by way of married deals.Post completion, OUE will hold an aggregate of 995.7m shares of IHC, representing a 57.60% stake.IHC has been suspended from trading since 14 February 2017 and has yet to resume trading.

On 16 February 2017, Oue Ltd (OUE SP) made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in International Healthway Corporation Ltd (IHC SP). The MGO was triggered after OUE entered into an S&amp;P agreement with Ching Chiat Kwong, Low See Ching, Low Bee Lan Audrey and Tee Wee Sien (collectively, the "Vendors") for the purchase of 593.5m shares at SGD 0.106 / share. This Acquisition will be completed by way of married deals.Post completion, OUE will hold an aggregate of 995.7m shares of IHC, representing a 57.60% stake.IHC has been suspended from trading since 14 February 2017 and has yet to resume trading. 

International Healthway - OUE Buys a Controlling Stake Leading to an MGO

2016 was an interesting and exciting year in the event driven space with lots of bumps and unexpected breaks. In this insight, we take a look at interesting statistics on M&amp;A deals we covered over the year. We highlight key points of certain interesting deals that concluded in 2016 and round up the note with key trends we expect to see in 2017.

2016 was an interesting and exciting year in the event driven space with lots of bumps and unexpected breaks. In this insight, we take a look at interesting statistics on M&amp;A deals we covered over the year. We highlight key points of certain interesting deals that concluded in 2016 and round up the note with key trends we expect to see in 2017.

Smartkarma Event Driven: 2016 Year in Review

Asia Economist and CEO, Centennial Asia Advisors

Manu Bhaskaran

Asia Economist and CEO

Centennial Asia Advisors

At Centennial Asia Advisors, we tell it like it is. We have no vested interests, no need for a China wall, and no reason to skew our outlook any other way. With over 30 years experience covering Asia’s political economy, you can be sure our conclusions and analyses are based on the unadulterated facts. Through years of fine-tuning our research methodologies, we deliver a quality of macroeconomic analysis few other houses can match.

Centennial Asia Advisors is an independent research and advisory firm that works with governments, multilateral institutions, financial firms and leading MNCs.

Economic Policy and Strategic Advisors

Macroeconomics

The death of <a href="http://www.rememberingleekuanyew.sg/" target="_blank">Lee Kuan Yew</a>&nbsp;takes away from Singapore the presence of the most important personality in its modern history and is a moment of deep sadness for all Singaporeans including those of us at <a href="http://www.centennialasia.com/" target="_blank">Centennial Asia</a>.His extraordinary leadership at crucial moments in Singapore&rsquo;s history - the traumatic merger and then separation with Malaysia, the confrontation with Indonesia, ethnic tensions, and countless economic challenges and crises - made what is Singapore today. His record of decisiveness and pragmatism and his success in creating strong institutions and a durable national consensus that unites the country mark him out from other leaders of developing nations.<blockquote>Some analysts have suggested that his passing could weaken Singapore, perhaps even create some political instability. The evidence suggests otherwise.</blockquote>

The death of Lee Kuan Yew&nbsp;takes away from Singapore the presence of the most important personality in its modern history and is a moment of deep sadness for all Singaporeans including those of us at Centennial Asia.His extraordinary leadership at crucial moments in Singapore&rsquo;s history - the traumatic merger and then separation with Malaysia, the confrontation with Indonesia, ethnic tensions, and countless economic challenges and crises - made what is Singapore today. His record of decisiveness and pragmatism and his success in creating strong institutions and a durable national consensus that unites the country mark him out from other leaders of developing nations.Some analysts have suggested that his passing could weaken Singapore, perhaps even create some political instability. The evidence suggests otherwise.

Singapore: Lee Kuan Yew's enduring legacy of strong institutions will see Singapore through

Founder of Innovation Research & Advisory firm, Lightbulb Capital

Daniel Liebau

Founder of Innovation Research & Advisory firm

Lightbulb Capital

Thematic (Sector/Industry)

Companies across different industries are building Innovation centers&nbsp; in Singapore, Hong Kong and other cities across Asia and the rest of the world.&nbsp; Some examples include <a target="_blank" href="http://aia-accelerator.com/">AIA</a>, <a target="_blank" href="http://www.3m.com.hk/intl/hk/english/in_hongkong/innovation_center.html">3M</a>, <a target="_blank" href="http://www.mis-asia.com/tech/industries/metlife-announces-futurelab-in-singapore/">MetLife</a> and <a target="_blank" href="https://www.edb.gov.sg/content/edb/en/news-and-events/news/2014-news/p-and-g-opens-250-million-innovation-centre.html">P&amp;G</a> amongst others.&nbsp;While this is a good step in the right direction there are 4 specific points that are worth considering to gauge if the initiative has a chance to create some optionality for future long term growth. Therefore, from an investment perspective it makes sense to evaluate Innovation initiatives in target companies with those points in mind.

Companies across different industries are building Innovation centers&nbsp; in Singapore, Hong Kong and other cities across Asia and the rest of the world.&nbsp;  Some examples include AIA, 3M, MetLife and P&amp;G amongst others.&nbsp;While this is a good step in the right direction there are 4 specific points that are worth considering to gauge if the initiative has a chance to create some optionality for future long term growth. Therefore, from an investment perspective it makes sense to evaluate Innovation initiatives in target companies with those points in mind. 

Can Innovation labs be assessed to pick stocks for your portfolio?

Singapore

Healthway Medical Corp. Ltd. provides outpatient medical services in Singapore. The Company offers care in the areas of family medicine, specialists care, dental and oral care and medical aesthetics.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Healthway Medical Corp (HMED SP)

SGX Healthcare Index Outperformed Asian Benchmark in YTD

Singapore Exchange Ltd (SGX)

International Healthway - OUE Buys a Controlling Stake Leading to an MGO

On 16 February 2017, Oue Ltd (OUE SP) made a mandatory unconditional general offer ("MGO") for all the issued ordinary shares in International...

Crispin Francis

Smartkarma Event Driven: 2016 Year in Review

2016 was an interesting and exciting year in the event driven space with lots of bumps and unexpected breaks. In this insight, we take a look at...

Crispin Francis

Singapore: Lee Kuan Yew's enduring legacy of strong institutions will see Singapore through

The death of Lee Kuan Yew takes away from Singapore the presence of the most important personality in its modern history and is a moment of deep...

Manu Bhaskaran

Can Innovation labs be assessed to pick stocks for your portfolio?

Companies across different industries are building Innovation centers in Singapore, Hong Kong and other cities across Asia and the rest of the...

Daniel Liebau

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)